跳至主要内容
临床试验/NCT05691166
NCT05691166进行中(未招募)不适用

Reducing Falls With Progressive Resistance Training (ReFit) for the Oldest Old Adults With Sarcopenia. A 12-month Randomised Controlled Trial (RCT).

Norwegian University of Science and Technology1 个研究点 分布在 1 个国家目标入组 241 人开始时间: 2023年3月30日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
241
试验地点
1
主要终点
Falls

研究概览

简要总结

This study will investigate the effects of 12 months of high-intensity progressive resistance training compared with a control group on fall-rate in older adults with sarcopenia.

详细描述

Despite the wealth of theoretical benefits, existing literature on resistance training for falls prevention is not conclusive, given the sub-optimal resistance training paradigms, poor study quality, and use of multimodal training interventions, precluding isolation of the resistance training benefits. It is also possible that resistance training benefits for falls reduction will be most evident in those with sarcopenia to begin with as a risk factor for their falls. We will therefore conduct a randomised, controlled trial assessing the effects of resistance training reduce falls in the oldest old adults with sarcopenia, as well as to increase strength and muscle mass.

Amendments: 2024-09-18. We updated the low grip-strength inclusion criterion from [Men:<39.6kg, Women:<21.4kg] to [Men:<41.6kg, Women:23.4kg] based on normative values (Ref: Svinøy, O. E., Hilde, G., Bergland, A., & Strand, B. H. [2023]).

Extension amendment (2025-09-02): With new funding and ethics approval (REK 2022/462261), we added post-trial follow-up at 24 and 36 months to evaluate disability-free survival and the durability of effects on falls and several secondary outcomes. Falls during follow-up are collected via 12-month recall. No changes to interventions or the prespecified 0-12-month primary endpoints.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
80 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 80 years or older
  • Low muscular strength (grip strength: <41.3 kg for males and <23.4 kg for females [from 18.09.2024] or chair stand >15 seconds)
  • Community-dwelling incl. independent senior housing
  • Ambulatory without supervision or physical assistance from another person. Assistive devices such as canes/crutches/walkers allowed.
  • Able to see and hear sufficiently to undertake assessments and partake in the planned exercise training.

排除标准

  • Pre-existing diagnosis of dementia
  • Moderate or severe cognitive impairment (score <18 on the Mini-Mental State Examination)
  • Living in institutional care
  • Non-ambulatory or requiring person or wheelchair to assist when walking
  • Degenerative neurological and neuromuscular disease/disorder significantly influencing gait and mobility (e.g. amyotrophic lateral sclerosis [ALS] and Parkinson's disease).
  • Amputation (other than toes)
  • Contraindications to resistance training
  • Unstable fracture
  • Inability to comply with study requirements
  • Currently undertaking progressive resistance training

结局指标

主要结局

Falls

时间窗: 12 months

Relative risk for falls, fall rate per person years. Self-report.

次要结局

  • Dynamic muscular strength(6 and 12 months)
  • Dynamic muscular strength(6 and 12 months)
  • Falls requiring medical attention(6, 12, 24, 36 months)
  • Fall-related injuries(6, 12, 24, 36 months)
  • Falls(6, 12, 24, and 36 months.)
  • Grip strength(6, 12, 24, 36 months)
  • Muscular power(6 and 12 months)
  • Physical performance(6, 12, 24, 36 months)
  • Balance(6, 12, 24, 36 months)
  • Stature(6, 12, 24, 36 months)
  • Body mass(6, 12, 24, 36 months)
  • Body composition(6, 12, 24, 36 months)
  • Circumferences(6 and 12 months)
  • Resting blood pressure and resting heart rate(6, 12, 24, 36 months)
  • Orthostatic blood pressure(6, 12, 24, 36 months)
  • Physical activity(6, 12, 24, 36 months)
  • Health-related quality of life(6, 12, 24, 36 months)
  • Fear of falling(6, 12, 24, 36 months)
  • Cognitive function(6 and 12 months)
  • Depression(6, 12, 24, 36 months)
  • Frailty(6, 12, 24, 36 months)
  • Nutritional status(6, 12, 24, 36 months)
  • Sleep quality(6, 12, 24, 36 months)
  • Hospital admissions(0-12 months and 0-36 months)
  • Use of primary health care, community care, and assistive technology(0-12 months and 0-36 months)
  • Use of prescription drugs(12 months)
  • Disability-free survival (DFS)(Baseline to 36 months post-randomisation)
  • Healthcare and implementation costs(0-12 months)
  • Quality-Adjusted Life-Years (QALY's)(0-12 months)
  • Falls(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验